Fig. 5From: Emerging trends in the coexistence of primary lung Cancer and hematologic malignancy: a comprehensive analysis of clinicopathological features and genetic abnormalitiesThe survival outcomes of each subgroup. (A) OS in hematologic malignancy-related genetic abnormalities. (B) OS in lung cancer surgical history. (C) OS in staging subgroups of lung cancer among multiple primary cancers. (D) OS in PS score of lung cancer. (E) OS in pathological subgroups of lung cancer. (F) OS in subgroups with different time intervals between two tumorsBack to article page